Redhill Biopharma Ltd (NASDAQ:RDHL)

17.38
Delayed Data
As of 2:47pm ET
 -0.43 / -2.41%
Today’s Change
6.89
Today|||52-Week Range
22.22
+30.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$175.4M

Company Description

RedHill Biopharma Ltd. is a biopharmaceutical company, which engages in the development and acquisition of late clinical-stage, proprietary, and orally-administered drugs for the treatment of inflammatory and gastrointestinal diseases. Its product pipeline includes RHB-105, RHB-104, RHB-106, Bekinda, ABC294640, Mesupron, RP101, and Rizaport. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Contact Information

RedHill Biopharma Ltd.
21 Ha'arba'a Street
Tel Aviv Tel Aviv 64739
P:(723) 541-3131
Investor Relations:

Employees

Shareholders

Other institutional14.23%
Mutual fund holders0.21%
Individual stakeholders--

Top Executives

Dror Ben-AsherChairman & Chief Executive Officer
Ori ShiloDirector, Deputy CEO-Finance & Operations
Reza FathiSenior Vice President-Research & Development
Guy GoldbergChief Business Officer
Ira N. KalfusMedical Director

To view my watchlist

Not a member yet?

Sign up now for a free account